eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding eFFECTOR Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 24 | 27 | +3 |
| Shares | 24.1M | 24.0M | −157.5K (−0.7%) |
| Value | $33.9M | $13.7M | −$20.2M (−59.7%) |
New holders (6)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wescott Financial Advisory Group, LLC | 55,556 | $32.0K | 0.01% |
| Two Sigma Investments, LP | 47,223 | $27.0K | 0.00% |
| We Are One Seven, LLC | 20,070 | $11.0K | 0.00% |
| Millennium Management LLC | 16,047 | $9.00K | 0.00% |
| Two Sigma Securities, LLC | 16,201 | $9.00K | 0.00% |
| UBS Group AG | 16,558 | $9.00K | 0.00% |
Sold out (3)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Norges Bank | 416,300 | $591.1K |
| Virtu Financial LLC | 15,667 | $22.0K |
| Penserra Capital Management LLC | 5,108 | $7.00K |